Anti-Human CD18 Recombinant Antibody F(ab')2 Fragment (TAB-154-F(E)) (CAT#: TAB-154-F(E))
Recombinant antibody Fragment F(ab')2 to CD18. This antibody is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. It treats heart attack, stroke, and traumatic shock.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 Anti-Human CD18 Recombinant Antibody, hIgG1 (TAB-154-F(E)) in SDS-PAGE
SDS-PAGE analysis of TAB-154-F(E) in non-reduced (Lane 2) and reduced (Lane 1) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result, different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
The purity of TAB-154-F(E) was greater than 95% as determined by SDS-PAGE.
Figure 2 Anti-Human CD18 Recombinant Antibody, hIgG1 (TAB-154-F(E)) in HPLC
The purity of TAB-154-F(E) was greater than 95% as determined by SEC-HPLC.
Specifications
- Immunogen
- Tissue / cell preparation (Human). (Leucocytes of a patient suffering from a LGL-type leukaemia).
- Host Species
- Mouse
- Derivation
- Humanized (from mouse)
- Type
- IgG1
- Specificity
- Tested positive against native human antigen.
- Species Reactivity
- Human
- Applications
- Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods.
- Related Disease
- Unknown
Product Property
- Purity
- >95.0% as determined by analysis by SDS-PAGE.
- Storage
- Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Target
- Alternative Names
- Erlizumab;211323-03-4;rhuMAb CD18;rhuMAb;ITGB2;integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);CD18, integrin, beta 2 (antigen CD18 (p95), lymphocyte function associated antigen 1;macrophage antigen 1 (mac 1) beta subunit) , MFI7;integr
- Gene ID
- 3689
- UniProt ID
- P05107
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "ITGB2"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-099 | Recombinant Anti-Human ITGB2 VHH Single Domain Antibody | ELISA, IHC, FC, FuncS | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-154-F(E). Click the button above to contact us or submit your feedback about this product.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# TAB-154-F(E), RRID: AB_3111840)
Popular products with customers
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: Inhib, Cyt
Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: WB, ELISA, FuncS
Application: ELISA, IP, WB, IHC, IF, FuncS
Application: ELISA
Application: WB, IF, FuncS
Application: WB, ELISA, FC, IHC, IP
Application: ELISA, WB, FC
Application: ELISA, WB
Application: ELISA
Application: ELISA, Activ, Block
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.